The Th1-Th2 hypothesis of HIV infection: new insights.
暂无分享,去创建一个
[1] F. Annunziato,et al. Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection , 1994, The Journal of experimental medicine.
[2] T. Mosmann,et al. Cytokine patterns during the progression to AIDS. , 1994, Science.
[3] A. Fauci,et al. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. , 1994, Science.
[4] M. de Carli,et al. Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. , 1994, Science.
[5] S. Lightman,et al. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. , 1994, Immunology today.
[6] R. de Waal Malefyt,et al. IL-12 transiently induces IFN-gamma transcription and protein synthesis in human CD4+ allergen-specific Th2 T cell clones. , 1994, International immunology.
[7] M. Clerici,et al. An immunoendocrinological hypothesis of HIV infection , 1994, The Lancet.
[8] F. Erard,et al. Non-cytotoxic, IL-4, IL-5, IL-10 producing CD8+ T cells: their activation and effector functions. , 1994, Current opinion in immunology.
[9] A. Lazzarin,et al. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV‐infected patients , 1994, AIDS.
[10] B. Wahrén,et al. Increased levels of interferon‐gamma (IFN‐γ), IL‐4 and transforming growth factor‐beta (TGF‐β) mRNA expressing blood mononuclear cells in human HIV infection , 1994 .
[11] G. Trinchieri,et al. Impaired interleukin 12 production in human immunodeficiency virus- infected patients , 1994, The Journal of experimental medicine.
[12] N. Jenkins,et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.
[13] É. Oksenhendler,et al. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. , 1994, The Journal of clinical investigation.
[14] U. Dittmer,et al. Immunization of macaque monkeys with low- and high-dose regimens of SIVmac results in different immune responses. , 1994, Immunology today (Amsterdam. Regular ed.).
[15] J. Berzofsky,et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. , 1994, The Journal of clinical investigation.
[16] J. Berzofsky,et al. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. , 1994, JAMA.
[17] J. Berzofsky,et al. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. , 1993, Science.
[18] F. Miedema,et al. Protection from HIV infection or AIDS? , 1993, Science.
[19] S. Robinson,et al. Unidirectional coupling of gap junctions between neuroglia. , 1993, Science.
[20] J. Levy,et al. HIV pathogenesis and long-term survival. , 1993, AIDS.
[21] G. Rook,et al. TH1/TH2 switching and loss of CD4+ T cells in chronic infections: an immunoendocrinological hypothesis not exclusive to HIV. , 1993, Immunology today.
[22] J. Berzofsky,et al. Cellular immune factors associated with mother‐to-infant transmission of HIV , 1993, AIDS.
[23] J. Cohen. T cell shift: key to AIDS therapy? , 1993, Science.
[24] A. Rees,et al. Striking the right balance; the role of cytokines in mycobacterial disease , 1993, Clinical and experimental immunology.
[25] A. Sher,et al. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. , 1993, Journal of immunology.
[26] J. Abrams,et al. Cytokine production at the site of disease in human tuberculosis , 1993, Infection and immunity.
[27] L. Montaner,et al. Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro , 1993, The Journal of experimental medicine.
[28] P. Gladstone. AIDS progression: protection by TH1 lymphokines in different HLA-DR genotypes. , 1993, Immunology today.
[29] G. Gros,et al. Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells. , 1993, Science.
[30] E. Browne,et al. Dehydroepiandrosterone regulation of the hepatic glucocorticoid receptor in the zucker rat. The obesity research program , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[31] M. Clerici,et al. A strategy for prophylactic vaccination against HIV. , 1993, Science.
[32] P. Scott. IL-12: initiation cytokine for cell-mediated immunity. , 1993, Science.
[33] S. Rowland-Jones,et al. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant , 1993, The Lancet.
[34] C. Pirmez,et al. Cytokine patterns in the pathogenesis of human leishmaniasis. , 1993, The Journal of clinical investigation.
[35] B. Bloom. The power of negative thinking. , 1993, The Journal of clinical investigation.
[36] Wynn,et al. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. , 1993, The Journal of clinical investigation.
[37] D. Venzon,et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. , 1993, The Journal of clinical investigation.
[38] J. Bilezikian,et al. HIV disease and the endocrine system. , 1992, The New England journal of medicine.
[39] W. Paul,et al. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice , 1992, The Journal of experimental medicine.
[40] T. Fitzgerald,et al. The Th1/Th2-like switch in syphilitic infection: is it detrimental? , 1992, Infection and immunity.
[41] C. Griscelli,et al. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus‐1‐infected mothers , 1992, European journal of immunology.
[42] J. Berzofsky,et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. , 1992, The Journal of infectious diseases.
[43] J. Berzofsky,et al. Role of T‐Cell Derived Cytokines in the Downregulation of Immune Responses in Parasitic and Retroviral Infection , 1992, Immunological reviews.
[44] J. Berzofsky,et al. Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen. , 1992, Journal of immunology.
[45] P. Krijnen,et al. Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men. , 1992, The Journal of infectious diseases.
[46] A. Capron,et al. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals , 1992, The Journal of experimental medicine.
[47] R. Fusaro,et al. Decreased serum dehydroepiandrosterone is associated with an increased progression of human immunodeficiency virus infection in men with CD4 cell counts of 200-499. , 1991, The Journal of infectious diseases.
[48] K. Weinberg,et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.
[49] M. Clerici,et al. Human immunodeficiency virus infection in the US Air Force: seroconversions, clinical staging, and assessment of a T helper cell functional assay to predict change in CD4+ T cell counts. , 1991, The Journal of infectious diseases.
[50] S. Romagnani. Human TH1 and TH2 subsets: doubt no more. , 1991, Immunology today.
[51] J. Berzofsky,et al. Exposure to Human Immunodeficiency Virus Type I-Specific T Helper Cell Responses before Detection of Infection by Polymerase Chain Reaction and Serum Antibodies , 1991 .
[52] J. Berzofsky,et al. Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection , 1991, European journal of immunology.
[53] A. Capron,et al. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. , 1991, Immunology today.
[54] A. Sher,et al. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni , 1991, The Journal of experimental medicine.
[55] A. Weinberg,et al. IL-4 directs the development of Th2-like helper effectors. , 1990, Journal of immunology.
[56] P. Barnes,et al. Pleuritis as a manifestation of reactivation tuberculosis. , 1990, The American journal of medicine.
[57] M. Clerici,et al. Circumvention of defective CD4 T helper cell function in HIV-infected individuals by stimulation with HLA alloantigens. , 1990, Journal of immunology.
[58] W. Borkowsky,et al. Lymphocyte proliferative responses to HIV-1 envelope and core antigens by infected and uninfected adults and children. , 1990, AIDS research and human retroviruses.
[59] J. Phair,et al. A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection A report from the Multicenter AIDS Cohort Study , 1990, The Lancet.
[60] R. Lockey,et al. Serum IgE and human immunodeficiency virus (HIV) infection. , 1990, The Journal of allergy and clinical immunology.
[61] D. Ho,et al. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1989, The New England journal of medicine.
[62] M. Clerici,et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. , 1989, The Journal of clinical investigation.
[63] R. Daynes,et al. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4 , 1989, European journal of immunology.
[64] P. Möller,et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. , 1989, Science.
[65] M. Grieco,et al. Immunoglobulins and hypersensitivity in human immunodeficiency virus (HIV) infection. , 1989, The Journal of allergy and clinical immunology.
[66] S. Yonehara,et al. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.
[67] J. Levy,et al. A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. , 1989, Immunology.
[68] J. Ghrayeb,et al. T-cell response towards HIV in infected individuals with and without zidovudine therapy, and in HIV-exposed sexual partners. , 1989, AIDS.
[69] J. Parkin,et al. Atopic manifestations in the acquired immune deficiency syndrome: response to recombinant interferon gamma. , 1987, British medical journal.
[70] A. J. Crowle,et al. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria , 1985, Infection and immunity.
[71] R. Gallo,et al. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals wi , 1985, The Journal of clinical investigation.
[72] K. Smith,et al. Hypereosinophilia secondary to immunodysregulation in patients with HIV-1 disease. , 1994, Archives of dermatology.
[73] J. D. de Vries,et al. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. , 1994, Immunology today.
[74] M. Clerici,et al. A TH1-->TH2 switch is a critical step in the etiology of HIV infection. , 1993, Immunology today.
[75] M. Clerici,et al. T helper cell immune dysfunction in asymptomatic, HIV-1-seropositive individuals: the role of TH1-TH2 cross-regulation. , 1992, Chemical immunology.
[76] J. Andrieu,et al. Elevation of IgE in HIV-infected subjects: a marker of poor prognosis. , 1992, The Journal of allergy and clinical immunology.